M
Michele K. Bohm
Researcher at Centers for Disease Control and Prevention
Publications - 38
Citations - 3141
Michele K. Bohm is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Medical prescription & Population. The author has an hindex of 17, co-authored 35 publications receiving 2356 citations.
Papers
More filters
Journal ArticleDOI
Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.
Gery P. Guy,Kun Zhang,Michele K. Bohm,Jan L. Losby,Brian Lewis,Randall Young,Louise B. Murphy,Deborah Dowell +7 more
TL;DR: Despite reductions in opioid prescribing in some parts of the country, the amount of opioids prescribed remains high relative to 1999 levels and varies substantially at the county-level, and health care providers should carefully weigh the benefits and risks when prescribing opioids.
Journal ArticleDOI
Opioid Use Disorder Documented at Delivery Hospitalization — United States, 1999–2014
TL;DR: Nationally, the prevalence of opioid use disorder more than quadrupled during 1999–2014 and increasing trends over time were observed in all 28 states with available data (p<0.05).
Journal Article
Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.
TL;DR: Rates of heroin abuse or dependence were strongly positively correlated with rates of heroin-related overdose deaths over time and were highest among those with past-year cocaine or opioid pain reliever Abuse or dependence.
Journal ArticleDOI
County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.
Michelle Van Handel,Charles E. Rose,Elaine Hallisey,J. Kolling,Jon E. Zibbell,Brian Lewis,Michele K. Bohm,Christopher M. Jones,Barry Flanagan,Azfar-e-Alam Siddiqi,Kashif Iqbal,Andrew L. Dent,Jonathan Mermin,Eugene McCray,John W. Ward,John T. Brooks +15 more
TL;DR: This analysis highlights US counties potentially vulnerable to HIV and HCV infections among PWID in the context of the national opioid epidemic and identifies 220 counties in 26 states within the 95th percentile of most vulnerable.
Journal ArticleDOI
Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs - Six Sites, 2005-2016.
Kelly A. Jackson,Michele K. Bohm,John T. Brooks,Alice Asher,Joelle Nadle,Wendy Bamberg,Sue Petit,Susan M. Ray,Lee H. Harrison,Ruth Lynfield,Ghinwa Dumyati,William Schaffner,John M. Townes,Isaac See +13 more
TL;DR: The effects of the opioid epidemic on invasive methicillin-resistant Staphylococcus aureus (MRSA) infections during 2005-2016 were assessed, and surveillance data from CDC's Emerging Infections Program (EIP) were analyzed.